These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18575712)

  • 21. K-ras and p53 gene mutations in colorectal cancer in 57 Japanese patients.
    Onda M; Abe R; Tsuchiya A; Fukushima T; Ando Y; Yoshida T
    Fukushima J Med Sci; 1997 Jun; 43(1):29-39. PubMed ID: 9431782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
    Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
    Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. beta-Catenin and ras oncogenes detect most human colorectal cancer.
    Zhang B; Ougolkov A; Yamashita K; Takahashi Y; Mai M; Minamoto T
    Clin Cancer Res; 2003 Aug; 9(8):3073-9. PubMed ID: 12912959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells.
    Takezawa K; Okamoto I; Yonesaka K; Hatashita E; Yamada Y; Fukuoka M; Nakagawa K
    Cancer Res; 2009 Aug; 69(16):6515-21. PubMed ID: 19638574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12.
    Céspedes MV; Sancho FJ; Guerrero S; Parreño M; Casanova I; Pavón MA; Marcuello E; Trias M; Cascante M; Capellà G; Mangues R
    Carcinogenesis; 2006 Nov; 27(11):2190-200. PubMed ID: 16679305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
    Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R
    J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas.
    Lee JW; Soung YH; Seo SH; Kim SY; Park CH; Wang YP; Park K; Nam SW; Park WS; Kim SH; Lee JY; Yoo NJ; Lee SH
    Clin Cancer Res; 2006 Jan; 12(1):57-61. PubMed ID: 16397024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf.
    Dwivedi Y; Rizavi HS; Conley RR; Pandey GN
    Mol Psychiatry; 2006 Jan; 11(1):86-98. PubMed ID: 16172610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High nuclear expression of phosphorylated extracellular signal-regulated kinase in tumor cells in colorectal glands is associated with poor outcome in colorectal cancer.
    Tai CJ; Lee CH; Chen HC; Wang HK; Jiang MC; Su TC; Shen KH; Lin SH; Yeh CM; Chen CJ; Yeh KT; Chang CC
    Ann Diagn Pathol; 2013 Apr; 17(2):165-71. PubMed ID: 23183114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
    Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
    Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of B-RAF and N-RAS mutations in human melanoma.
    Goydos JS; Mann B; Kim HJ; Gabriel EM; Alsina J; Germino FJ; Shih W; Gorski DH
    J Am Coll Surg; 2005 Mar; 200(3):362-70. PubMed ID: 15737846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-Raf is required for ERK activation and tumor progression in a mouse model of pancreatic beta-cell carcinogenesis.
    Sobczak I; Galabova-Kovacs G; Sadzak I; Kren A; Christofori G; Baccarini M
    Oncogene; 2008 Aug; 27(35):4779-87. PubMed ID: 18490924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancer.
    Kemper K; Versloot M; Cameron K; Colak S; de Sousa e Melo F; de Jong JH; Bleackley J; Vermeulen L; Versteeg R; Koster J; Medema JP
    Clin Cancer Res; 2012 Jun; 18(11):3132-41. PubMed ID: 22496204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis.
    Buchmann A; Karcier Z; Schmid B; Strathmann J; Schwarz M
    Mutat Res; 2008 Feb; 638(1-2):66-74. PubMed ID: 17928010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
    Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
    Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional analysis of mutations within the kinase activation segment of B-Raf in human colorectal tumors.
    Ikenoue T; Hikiba Y; Kanai F; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Aragaki J; Matsumura M; Kawabe T; Omata M
    Cancer Res; 2003 Dec; 63(23):8132-7. PubMed ID: 14678966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of Kruppel-like factor 6 (KLF6) mutation in the development of nonpolypoid colorectal carcinoma.
    Mukai S; Hiyama T; Tanaka S; Yoshihara M; Arihiro K; Chayama K
    World J Gastroenterol; 2007 Aug; 13(29):3932-8. PubMed ID: 17663506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics.
    Levidou G; Saetta AA; Gigelou F; Karlou M; Papanastasiou P; Stamatelli A; Kavantzas N; Michalopoulos NV; Agrogiannis G; Patsouris E; Korkolopoulou P
    World J Surg Oncol; 2012 Feb; 10():47. PubMed ID: 22376079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative screening of K-ras mutations in colorectal cancer and lung cancer patients using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing.
    Zhang H; Zheng X; Ji T; Fu L; Bai D; Liao Y; Zhang H; Ding Y; Zheng L
    Cell Biochem Biophys; 2012 Apr; 62(3):415-20. PubMed ID: 22048888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.